Sommadossi Jean-Pierre

Idenix Pharmaceuticals Inc.

President, CEO, Chairman, Director

Avg. Two Year Performance

(36%) Avg. Purchase Return (17%) Compound

No Sale Track Record

Holdings: 2.22M shares

Last Three Months: 14-Feb-24 -- 13-May-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Biotechnology

Drugs

Two Year Chart

14-May-22 -- 13-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions